New York, New York 10011


Purpose:

The primary aim of this study is to assess and compare change in QOL during chemotherapy as measured by the Functional Assessment of Cancer Therapy-Breast (FACT-Breast) score between patients receiving yoga and those not receiving yoga. Secondary endpoints will include other measures of QOL such as sleep quality measured with the Pittsburg Sleep Quality Inventory (PSQI), anxiety and depression using Hospital Anxiety and Depression Scale (HADS), and adherence to yoga and to chemotherapy treatment.


Criteria:

Inclusion Criteria: - Age>18 years - History of stage I-III breast cancer - Patient scheduled to receive or within 2 weeks of receiving intravenous chemotherapy for their breast cancers - Eastern Cooperative Oncology Group Performance status of <3 - Ability to understand English 5.2 Exclusion Criteria: - Planning to start yoga on their own within the next 12 weeks - Maintained a regular personal practice or yoga within the 3 months before enrolling onto the study - Severe chronic obstructive pulmonary disease - Class III or IV heart failure - Child C cirrhosis - End-Stage renal disease Exclusion Criteria: - Planning to start yoga on their own within the next 12 weeks - Maintained a regular personal practice or yoga within the 3 months before enrolling onto the study - Severe chronic obstructive pulmonary disease - Class III or IV heart failure - Child C cirrhosis - End-Stage renal disease


NCT ID:

NCT02360904


Primary Contact:

Principal Investigator
Theresa Shao, MD
Beth Israel Medcial Center

Sherly Jacob-Perez, B.S.
Phone: 2123670186
Email: sjacob@chpnet.org


Backup Contact:

N/A


Location Contact:

New York, New York 10011
United States

Sherly Jacob-Perez, B.S.
Phone: 212-367-0186
Email: sjacob@chpnet.org

Site Status: Recruiting


Data Source: ClinicalTrials.gov

Date Processed: March 16, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

If you would like to be contacted by the clinical trial representative please fill out the form below.